Authors: ZURLO M PORRO MG DEBESI P GRAMEGNA P MARTINOTTI A RIGGI M

Citation: M. Zurlo et al., RANDOMIZED OPEN-LABEL, MULTICENTER TRIAL ON THE LOCAL TOLERABILITY OFA READY-TO-USE FORMULATION OF IDARUBICIN FOR IV INJECTION, European journal of cancer, 34, 1998, pp. 128-128

Authors: WITJES WPJ HALL RR SCHULMAN CC ZURLO M FITTIPALDO A RIGGI M DEBRUYNE FMJ

Citation: Wpj. Witjes et al., BROPIRIMINE VERSUS BCG IN BCG-NAIVE PATIENTS WITH CARCINOMA IN-SITU OF THE URINARY-BLADDER - PRELIMINARY-RESULTS OF A EUROPEAN RANDOMIZED PHASE-III TRIAL, The Journal of urology, 159(5), 1998, pp. 553-553

Authors: MUGGETTI L ZURLO M MARTINI A CIVAROLI P DEPONTI R

Citation: L. Muggetti et al., PREFORMULATION ACTIVITIES OF INTRANASAL DOSAGE FORMS OF TEMAZEPAM, International journal of pharmaceutics, 136(1-2), 1996, pp. 81-88

Authors: BERAN M JEHA S OBRIEN S ESTEY E VITEK L ZURLO M RIOS MB KEATING M KANTARJIAN H

Citation: M. Beran et al., TALLIMUSTINE, AN EFFECTIVE ANTILEUKEMIC AGENT IN A SCID MOUSE MODEL OF ADULT MYELOGENOUS LEUKEMIA (AML), INDUCES REMISSIONS IN A PHASE STUDY, Blood, 88(10), 1996, pp. 868-868